BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7141063)

  • 1. Effects of etretinate (Ro 10-9359) on Darier's Disease.
    Löwhagen GB; Michaëlsson G; Mobacken H; Pettersson U; Vahlquist A
    Dermatologica; 1982 Aug; 165(2):123-30. PubMed ID: 7141063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
    Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE; Wishart J; Hodge JL
    N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H; Esca SA; Holubar K
    Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease.
    Christophersen J; Geiger JM; Danneskiold-Samsoe P; Kragballe K; Larsen FG; Laurberg G; Serup J; Thomsen K
    Acta Derm Venereol; 1992; 72(2):150-2. PubMed ID: 1350407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a new oral retinoid RO10 9359 in the treatment of Darier's disease.
    Watson AB
    Australas J Dermatol; 1980 Aug; 21(2):76-8. PubMed ID: 7447813
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of follicular dyskeratosis (Darier's disease) with aromatic vitamin A].
    Mária W; Miklós S
    Orv Hetil; 1981 Mar; 122(9):522-4. PubMed ID: 7290698
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Darier's disease with an oral aromatic retinoid (Ro 10-9359): a clinical and light and electron microscopic study.
    Lauharanta J; Niemi KM; Lassus A
    Acta Derm Venereol; 1981; 61(6):535-42. PubMed ID: 6177166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 11. [Darier's disease and renal polycystosis. Familial study and effects of aromatic retinoid].
    Claudy A; Toulon J; Dutoit M; Sabatier JC; Berthoux FC
    Ann Dermatol Venereol; 1981; 108(8-9):675-7. PubMed ID: 7316395
    [No Abstract]   [Full Text] [Related]  

  • 12. Excessive cerumen production due to the aromatic retinoid Tigason in a patient with Darier's disease.
    Kramer M
    Acta Derm Venereol; 1982; 62(3):267-8. PubMed ID: 6179378
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses.
    Viglioglia PA
    Br J Dermatol; 1980 Nov; 103(5):483-7. PubMed ID: 7437314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histochemical study of enzyme activities during etretinate treatment of Darier's disease.
    Löwhagen GB; Mobacken H; Heyden G
    Dermatol Monatsschr; 1982 Nov; 168(11):733-9. PubMed ID: 6897639
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and ultrastructural effects of acitretin in Darier's disease.
    Lauharanta J; Kanerva L; Turjanmaa K; Geiger JM
    Acta Derm Venereol; 1988; 68(6):492-8. PubMed ID: 2467487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of 'Tigason' (Ro 10-9359) on the serum lipoproteins in man.
    Michaëlsson G; Bergqvist A; Vahlquist A; Vessby B
    Br J Dermatol; 1981 Aug; 105(2):201-5. PubMed ID: 7284249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etretinate: effect of milk intake on absorption.
    DiGiovanna JJ; Gross EG; McClean SW; Ruddel ME; Gantt G; Peck GL
    J Invest Dermatol; 1984 Jun; 82(6):636-40. PubMed ID: 6233379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid-induced haemorrhagic bullae in Darier's disease.
    Gebauer K; Holgate C; Navaratnam A
    Australas J Dermatol; 1990; 31(2):99-103. PubMed ID: 2095739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eczema herpeticum in a patient with Darier's disease during treatment with etretinate.
    Verner E; Shteinfeld M; Zuckerman F
    J Am Acad Dermatol; 1985 Oct; 13(4):678-80. PubMed ID: 4078062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.